A detailed history of Talisman Wealth Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Talisman Wealth Advisors LLC holds 3,218 shares of AZN stock, worth $267,319. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,218
Previous 2,976 8.13%
Holding current value
$267,319
Previous $201,000 24.38%
% of portfolio
0.29%
Previous 0.25%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $16,168 - $19,560
242 Added 8.13%
3,218 $250,000
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $181,625 - $207,040
2,976 New
2,976 $201,000
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $978 - $1,061
-14 Reduced 0.48%
2,908 $208,000
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $184,524 - $209,215
2,922 New
2,922 $203,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $257B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Talisman Wealth Advisors LLC Portfolio

Follow Talisman Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Talisman Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Talisman Wealth Advisors LLC with notifications on news.